5Himta A,Ogawa S,Kometani T,et al.ZD1839(Iressa)induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase[J].Cancer Res,2002,62(9):2554-60.
6Parra HS,Cavina R,Latteri F,et al.Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib("Iressa",ZD1839)in non-small-cell lung cancer[J].Br J Cancer,2004,91(2):208-12.
8Mitsudomi T,KosakaT,Endoh H,et al.Mutations of the epidermal growth factor receptor gene predict prolonged survival after Gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence[J].Clin Oncol,2005,23:2513-20.
9Giaccone G,Herbst RS,Manegold C,et al.Gefitinib in combination with gemcitabine and cisplation in advanced non-small-cell lung cancer,a phase Ⅲ trial-intact[J].Clin Oncol,2004,22(5):777-84.
10Kosaka T,Yatabe Y,Endoh H,et al.Analysis of epidermal growth factor receptor gene mutation in patients with non-small-cell lung cancer and acquired resistance to gefitinib[J].Clin Cancer Res,2006,12(19):5764-9.
